Related Experiment Videos
Abstract:
Nine live virus veterinary vaccines from six sources were found to be contaminated with mycoplasma. The vaccines were for use in canine, feline and avian species, and 53 batches of the products were at fault. The isolates were identified as Mycoplasma hominis, M. arginini, M. orale, M. hyorhinis and M. gallinarum. Investigation of the contamination rate of other batches or other products from the same source in some cases helped to determine the source of infection. Mycoplasma contaminants can be considered important not only because of their role as pathogens but also because they may indicate that insufficient care has been taken during vaccine manufacture or quality control.
Insights
Mycoplasma contamination was found in nine live virus veterinary vaccines for dogs, cats, and birds. This contamination highlights potential issues in vaccine manufacturing and quality control processes.
Area of Science:
- Veterinary Medicine
- Microbiology
- Vaccinology
Background:
- Mycoplasma are common contaminants in cell cultures and biological products.
- Veterinary vaccines are critical for animal health, and their purity is paramount.
- Previous studies have identified Mycoplasma contamination in various biological products.
Purpose of the Study:
- To identify and characterize Mycoplasma contaminants in veterinary vaccines.
- To investigate the prevalence and potential sources of Mycoplasma contamination in vaccine batches.
- To assess the implications of Mycoplasma contamination for vaccine quality and safety.
Main Methods:
- Samples from nine live virus veterinary vaccines were collected from six different sources.
- Contaminated vaccine batches were identified through microbiological testing.
- Isolates were identified to the species level using molecular and biochemical methods.
- Investigation of contamination rates in other batches and products from the same source was conducted.
Main Results:
- Nine live virus veterinary vaccines, comprising 53 batches, were found to be contaminated with Mycoplasma.
- Contaminants were identified as Mycoplasma hominis, M. arginini, M. orale, M. hyorhinis, and M. gallinarum.
- The source of infection was determined in some cases by investigating contamination rates in related batches and products.
Conclusions:
- Mycoplasma contamination poses a significant risk in veterinary vaccine production.
- The presence of Mycoplasma indicates potential deficiencies in vaccine manufacturing and quality control.
- Ensuring Mycoplasma-free vaccines is crucial for animal health and public trust in veterinary biologics.